Gravitywell.Research
All ratings
Sector

Healthcare Services & Medtech · Sector

Grade
G3Sound
Outlook
Positive
Confidence
High
Score
61/100
PEGovt
Rating rationale

Structural demand (insurance penetration, medical tourism) meets institutional consolidation: Temasek/Blackstone-scale control deals, and the IPO wave now has its anchor print — Manipal listed 5 Aug 2026 at +11% on a ₹9,275 Cr issue. Multiples paid are full; the listing says the market pays them anyway.

Factor scorecard
Demand Outlook84/100 · Structural
Competition55/100 · Consolidating
Capital Intensity42/100 · High, priced higher
Risk-Adjusted Return62/100 · Operator's market
Rating history
Jun 2026InitiatedInaugural G3 (Sound), outlook Positive.
Aug 2026AffirmedG3 (Sound) affirmed on a material event: Manipal, the sector's largest platform, listed 5 Aug at +11% and held its premium — the valuation-cycle risk the grade discounts is now marked to a real print rather than a filing.

Point-in-time: grades are reviewed each cycle; every change publishes as a dated action. Snapshot 13 August 2026.

IMPORTANT: Gravitywell Research Ratings are independent, forward-looking RESEARCH OPINIONS / analytical assessments. They are NOT credit ratings issued by a SEBI-registered Credit Rating Agency, NOT a SEBI Research-Analyst recommendation, and NOT investment advice. Sovereign ratings shown for S&P, Moody's and Fitch are those agencies' own public ratings, cited for reference only. Sub-sovereign (state) and instrument grades are research opinions, not solicited ratings. Our opinions may change without notice and do not guarantee any outcome. Do your own research / consult a SEBI-registered adviser.